GlaxoSmithKline S.A.E (EGX:BIOC)
63.10
-0.79 (-1.24%)
At close: Dec 4, 2025
GlaxoSmithKline S.A.E Market Cap
GlaxoSmithKline S.A.E has a market cap or net worth of 5.27 billion as of December 5, 2025. Its market cap has increased by 46.71% in one year.
Market Cap
5.27B
Enterprise Value
6.19B
Revenue
3.74B
Ranking
n/a
PE Ratio
53.86
Stock Price
63.10
Market Cap Chart
Since August 23, 2005, GlaxoSmithKline S.A.E's market cap has increased from 569.45M to 5.27B, an increase of 825.41%. That is a compound annual growth rate of 11.59%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Commercial International Bank Egypt (CIB) S.A.E. | 353.12B |
| El Sewedy Electric Company | 166.41B |
| Talaat Moustafa Group Holding | 158.98B |
| Eastern Company S.A.E | 135.87B |
| Telecom Egypt Company | 105.75B |
| Qatar National Bank | 92.94B |
| Egypt Aluminum | 85.37B |
| Misr Fertilizer Production Company | 80.59B |